Chemotherapy-Induced Peripheral Neuropathy as a Predictor of Neuropathic Pain in Breast Cancer Patients Previously Treated With Paclitaxel
To access this article, please choose from the options below
GRANT SUPPORTED BY THE NATIONAL CANCER INSTITUTE (CA109043) and Pfizer, Inc.
PII: S1526-5900(09)00497-0
doi:10.1016/j.jpain.2009.04.006
© 2009 American Pain Society. Published by Elsevier Inc. All rights reserved.
